Hidradenitis Suppurativa: Examining the Role of Immunology and Inflammation with Biologics and JAK Inhibition

Dr. Raja Sivamani is a board-certified dermatologist and practices as an integrative dermatologist at Pacific Skin Institute. He is an Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis and Director of Clinical Research and the Clinical Trials Unit.He is also an Adjunct Assistant Professor in the Department of Biological Sciences at the California State University, Sacramento and an Associate Professor of Dermatology at California Northstate University, College of Medicine.He engages in clinical practice as well as both clinical and translational research that integrates bioengineering, nutrition, cosmetics, and skin biology. With training in both Allopathic and Ayurvedic medicine, he takes an integrative approach to his patients and in his research.He has published over 100 peer-reviewed research manuscripts, 10 textbook chapters, and a textbook entitled Cosmeceuticals and Active Cosmetics, 3rd Edition with a passion for expanding the evidence and boundaries of integrative medicine for skin care.

Dr. Daveluy is a professor and program director at Wayne State University in Detroit, Michigan. He earned a bachelor's in science from Michigan State University. He completed medical school and his dermatology residency at Wayne State University.

He holds special interests in teledermatology, noninvasive skin imaging, skin of color, integrative dermatology, and complex medical dermatology, including hidradenitis suppurativa. He is active on AAD committees, including Performance Measure and DataDerm Oversight. He is the past president of the Wayne County Medical Society and Michigan Dermatological Society. He serves on the board of directors of the HS Foundation and editorial board for the JAAD and JAAD Case Reports and is building a growing body of publications of his own. He lives across the border in Windsor, Ontario, Canada with his husband and two very spoiled dogs

Dr. Hawkes is a board-certified dermatologist and Investigator at the Oregon Medical Research Center in Portland, Oregon. He completed his medical school and residency at the University of Utah. During medical school, he completed a fellowship in translational immunology in the NIH-HHMI Research Scholars Program. He also received a Master’s Degree in Clinical Investigation from Rockefeller University, where he was Chief Clinical Scholar and Principal and sub-Investigator on multiple human research protocols in the Laboratory for Investigative Dermatology. He has held academic appointments in the Departments of Dermatology at the University of Utah, University of California-Davis, Icahn School of Medicine at Mount Sinai.

Dr. Hawkes is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee. He also serves as the official delegate of the AAD as a member of the international guidelines and workgroup committee for urticaria. His research has been funded by the NIH, NSF, NPF, and Dermatology Foundation, and he is the recipient of several teaching awards including NPF Outstanding Educator in Psoriatic Disease and Exceptional Teacher of the Year in the Department of Dermatology at Mount Sinai. His primary clinical and research interests include novel immune therapies for inflammatory conditions like psoriasis, atopic dermatitis, HS, alopecia areata, vitiligo, and urticaria.

Dr. John Frew is a fellow of the Australasian College of Dermatologists and a globally recognized researcher in Hidradenitis Suppurativa. He completed his medical degree (with Honours) from the University of New South Wales in 2009, followed by a Masters of Medicine in clinical epidemiology from the University of Sydney in 2011, followed by completing his dermatology specialist training in 2016. Dr. Frew recently completed a highly competitive post-doctoral fellowship at the prestigious Rockefeller University in New York City between 2018-2020 (under the guidance of Professor James Krueger), identifying immunological pathways and novel therapies for the treatment of Hidradenitis Suppurativa. Dr. Frew has over 100 peer-reviewed publications and contributed to numerous dermatology and immunology textbooks. He currently holds a staff specialist position at Liverpool Hospital and is a conjoint lecturer at the University of New South Wales, supervising dermatology trainees and postgraduate research students.

Dr. Hadar Lev-Tov is a board-certified dermatologist with extensive research experience. Throughout his training and in daily practice, he has always believed that the key to achieving health for his patients is grounded in his ability to truly connect to their experiences and perceptions of health and well-being. Maimonides, one of the greatest philosophers of all time realized that human knowledge, often represented as "science," is limited. As a physician, he feels he would be a fool to believe all is known. Maimonides said, "The physician should not treat the disease but the patient who is suffering from it." LearnSkin is his journey to a better understanding of his patients.

Dr. Kirby is a dermatologist and clinician-researcher at Penn State Hershey. She earned her Medical degree from the University of Virginia, then completed her Dermatology Residency at the University of Pennsylvania. In her clinical and research work, she is interested in acneiform conditions including acne, rosacea, and, especially, hidradenitis suppurativa – its effects on people, outcome measurement, and pathomechanisms. She is the PI of a number of clinical research trials. All of this is made possible by the support of her husband and two daughters.